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Abstract
Background: Primary care physicians (PCPs) play a key role regarding vaccination in France. The aims of the present
study were to define the scoring rules and to assess the measurement properties of the ‘Determinants of Intentions to
Vaccinate’ (DIVA©) questionnaire that aims to assess PCPs’ attitudes and beliefs toward vaccination.
Methods: The DIVA questionnaire was derived from a literature review and PCPs focus groups. Scoring and early
validation of the DIVA questionnaire were determined during a cross-sectional study conducted in France. During
the study, PCPs had to complete the DIVA questionnaire for any of the six vaccine-preventable diseases (VPDs) to which
they were randomly assigned (measles, pertussis, pneumococcus infection, seasonal influenza, human papillomavirus
-HPV- infection and tetanus). Descriptive analyses of items and the analysis of the grouping of items into domains were
conducted. Internal consistency reliability and construct validity was assessed according to each VPD.
Results: The DIVA questionnaire was completed by 1,069 PCPs and was well accepted. The ‘Commitment of the PCP to
the vaccination approach’ score showed very good internal consistency reliability (Cronbach’s alpha >0.70 overall and for
each VPD). The construct validity of the DIVA questionnaire was confirmed.
Conclusions: The DIVA questionnaire is a valid and reliable measure of PCPs’ attitudes and beliefs toward vaccination.
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Background
Vaccination is the most effective medical intervention
ever introduced [1, 2]. A recent study from the US
Centers for Disease Control and Prevention reported
that vaccination would have prevented 322 million
illnesses and 732,000 premature deaths in children
born during the period 1994–2013 [1, 3]. The smallpox
vaccination has been responsible for the total eradication
of the disease since its implementation in the 20th century
[2]. Similarly, vaccines prevent millions of cases of infec-
tious diseases worldwide, allowing for an increase in life
expectancy from 59 to 70 years from 1970 through 2010
[2]. Nevertheless, vaccination coverage is lower than de-
sired. From 2000 to 2010, the percentage of French
respondents who declared they were unfavourable to-
wards vaccination increased from 9 to 38 %, possibly due
to the 2009 influenza A (H1N1) pandemic [4].
Vaccination experts acknowledge that public confi-
dence in vaccination is waning [5, 6]. This “erosion in
trust” is illustrated by the decline of vaccination cover-
age and is observed in most developed countries. Other
evidence of the vaccine confidence gap is the increase in
controversies surrounding various vaccines: the measles,
mumps and rubella (MMR) vaccine in the United
Kingdom, the hepatitis B vaccine in France and the
H1N1 vaccine in many countries in 2009–2010 [5].
The relevance of the vaccination is also questioned by
healthcare professionals. A study reported that French
primary care physicians (PCPs) and paediatricians applied
loosely the 2010 recommended vaccination schedule [7].
The tendency of clinicians reconsidering vaccination is
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not limited to France. One study showed that only 42 % of
Italian paediatricians knew about the recommended vac-
cination schedule, and that only 10 % of Italian clinicians
had positive opinions regarding the usefulness of recom-
mended vaccinations [8]. In Canada, 37 % of healthcare
professionals considered that there were too many vac-
cines and 36 % of them considered that a good lifestyle
could eliminate the need for vaccination [9].
PCPs play a key role in the vaccination system in France.
The relationship between the patient and the PCP and
more generally healthcare professionals is the cornerstone
of maintaining public confidence in vaccination, including
addressing parents’ concerns on vaccines [9–11]. Several
studies have shown PCPs’ influences in the recommenda-
tions on vaccination to their patients [12–14].
It is therefore crucial to understand the factors that in-
fluence PCPs’ commitment to vaccination. To address this
need, the French Society of General Medicine (‘Société
Française de Médecine Générale’ -SFMG-) developed a
tool, the Determinants of Intentions to Vaccinate (DIVA©)
questionnaire, following a rigorous qualitative stepwise
methodology [15, 16]. The aims of the present study were
to define the scoring rules and to assess the measurement
properties of the DIVA tool.
Materials and methods
The DIVA questionnaire
The hypothetical conceptual framework of the DIVA
questionnaire included 56 items, grouped into six the-
matic domains and one commitment domain: ‘Disease
characteristics and expected benefits’ (9 items), ‘Properties
of the vaccine’ (10 items), ‘Information about the vac-
cination’ (8 items), ‘Practical and organisational aspects’
(6 items), ‘Adaptation to the patient’s profile’ (11 items),
‘PCP’s individual experience’ (5 items) and ‘PCP’s com-
mitment to the vaccination approach’ (7 items).
Study setting and design
An observational, cross-sectional and multi-centre study
involving French PCPs was conducted. All PCPs from the
mailing list of the SFMG were invited by email to partici-
pate in the study. PCPs who agreed to enter the study
were asked first to complete the socio-demographic form
on a website. PCPs were then randomly assigned to one of
the six vaccine-prevented diseases (VPDs) (measles, per-
tussis, pneumococcus infection, seasonal influenza, hu-
man papillomavirus -HPV- infection and tetanus) and
were asked to complete the DIVA questionnaire. As tet-
anus is a compulsory vaccine in France and was very well
accepted by PCPs during the qualitative phase, the tetanus
disease group was considered as a control group in the
study and thus included by design the smallest number of
PCPs (the allocation ratio was one PCP for tetanus for
three PCPs for each of the five other VPDs). There was no
eligibility criterion to enter the study.
A modified Delphi panel, composed of the members
of the DIVA scientific committee who are PCPs and spe-
cialists in vaccination, was carried out using the RAND/
UCLA method in the early stage of the study [17]. It was
conducted to appraise the position of the panellists on
the six thematic domains of the DIVA questionnaire ac-
cording to the six VPDs. The Delphi Panel was carried
out into 3 phases. In the first phase, panellists were
asked to complete a questionnaire with six propositions
corresponding to the six thematic domains of the DIVA
questionnaire for each VPD. Each proposition was pre-
sented in a numerical scale graduated from 1 to 9, with
1 indicating that the thematic domain was not a deter-
minant of decision-making in vaccinating against the
concerned VPD and 9 indicating that the thematic do-
main was a determinant of decision-making in vaccinat-
ing against the concerned VPD. In the second phase,
panellists discussed online their responses. In the third
phase, panellists were asked to complete the question-
naire again. At the end, each proposition was ranked ac-
cording to the agreement between the panellists and the
strength of the agreement.
Statistical analyses
Item selection and definition of the scoring rule were
based on the quality of completion of the DIVA ques-
tionnaire and on the distribution of item responses.
The DIVA questionnaire included both psychometric
and composite domains. A psychometric domain is
composed of items correlated with each other and
measuring a single concept. In the DIVA questionnaire,
the psychometric domain was the ‘PCP’s commitment
to the vaccination approach’ domain. A composite do-
main is composed of items that are a combination of
indicators of a common concept but not necessarily
correlated with each other. In the DIVA questionnaire,
composite domains were the six thematic domains. The
statistical methods that are described below were adapted
to the different natures of the concepts measured.
Principal component analysis (PCA) was performed to
challenge the hypothetical conceptual framework of the
DIVA questionnaire. This analysis aims at defining the
grouping of items into domains by examining the self-
organization of items [18]. Interpretable components
with an eigenvalue greater than one represented the em-
pirical domains.
An extension of the Rasch model, the Rating Scale
Model (RSM) used for polytomic response scale [19],
was performed on all items of the ‘PCP’s commitment to
the vaccination approach’ domain to validate the exist-
ence of a unique underlying construct (called the “latent
trait”) measuring the PCP’s commitment to vaccination
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[20]. All items were scaled with four categories (“Totally
disagree”, “Somewhat disagree”, “Somewhat agree” and
“Totally agree”). The Rasch model utilizes person and
item parameters to determine the probability of an item
score [21]. Raw scores for both persons and items are
transformed into measures (known as “locations”) using
a logistic mathematical function [21]. Model fit statistics
were computed to indicate whether all items met the
unidimensional measurement criterion using the resid-
uals (range of acceptability from −2.5 to 2.5 [21]) and
the item location to look at the deviation of the observed
data from the model expectation [22]. The person-item
threshold map, which is a graphical representation of
person and item locations (measured in logits) plotted
on the same latent trait along the x axis was also used.
The measurement properties of the DIVA question-
naire were assessed, including reliability and validity.
Reliability is the degree to which the instrument is
free from measurement error. Internal consistency reli-
ability (the extent to which items within a domain are
consistent with each other and measure a single under-
lying concept) was assessed for the ‘PCP’s commitment
to the vaccination approach’ domain, using Cronbach’s
alpha [23].
Validity is the degree to which the instrument measures
what it is supposed to measure. Construct validity was
conducted to assess the degree to which DIVA thematic
domains can distinguish the determinants of intentions to
vaccinate among the six VPDs groups. The hypotheses for
this analysis were formulated by the Delphi panel. The
ranks of DIVA thematic domains for each VPD calculated
from the Delphi panel were compared to those obtained
from descriptive analyses.
Ethical consideration
The present study was conducted in compliance with
national ethical principles and the list of the members of
the SFMG was submitted to the French National Com-
mission for Data Processing and Privacy (‘Commission
Nationale de l'Informatique et des Libertés’ -CNIL-).
Results
Population disposition
Among the 1,267 PCPs who completed the socio-
demographic form, 1,069 PCPs completed at least one
item of the DIVA questionnaire and constituted the ana-
lysis sample. The 1,069 PCPs were randomly assigned
into the measles disease group (N = 214), the pertussis
disease group (N = 203), the pneumococcus infection
disease group (N = 196), the seasonal influenza disease
group (N = 199), the HPV infection disease group (N = 184)
and the tetanus disease group (N = 73).
Characterization of PCPs
PCPs’ socio-demographic characteristics are presented in
Table 1. The majority of PCPs were male (58 %) with an
average age of 50 years. More than 90 % of PCPs had
less than 40 % of paediatric activity. Around half of PCPs
received medical representative visits and around a quar-
ter had attended training on vaccination in the last
12 months before the beginning of the study. Eighty five
percent of PCPs read the most recent weekly epidemio-
logical record.
Scoring rules of the DIVA questionnaire
Quality of completion
The quality of completion of the questionnaire was very
good. On average, there was less than one missing item per
questionnaire. Ninety percent of all PCPs (N = 959)
returned the DIVA questionnaire with all items completed.
Forty three items out of 56 had less than one percent miss-
ing data and the 13 remaining items had between one and
three percent missing data. The item with the highest num-
ber of missing data (N = 27) was about the PCP’s experience
of the disease on a personal level.
Distribution of the responses to items
The distribution of the responses to items was good
overall without bimodal distributions or floor effects.
However, 21 items had a response choice used by more
than 50 % of PCPs. Two pairs of redundant items were
identified. The first pair concerned items ‘efficacy of vac-
cination compared to other existing means of preventing’
and ‘efficacy of vaccination compared to that of the range




n (missing) 1069 (0)
Mean (SD) 49.8 (11.6)




Level of pediatric activity (%)
Between 0 and 20 % 46
Between 20 and 40 % 48
Between 40 and 60 % 5
More than 60 % 1
Medical representative visits (%) 52
Training on vaccination in the last 12 months (%) 23
Reading of the weekly epidemiological record
of April 2013 (%)
85
SD, Standard deviation
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of curative treatments’. The percentage of identical re-
sponses was 72 % and the Spearman correlation coeffi-
cient was 0.67. The redundancy might come from the
similarity in the wording of these two items despite a
clear difference in the concept (prevention vs. curative).
Thus, the two items were differentiated by putting ‘pre-
vention’ and ‘curative’ in bold letters. The second pair of
redundant items concerned items ‘I think about vaccin-
ation’ and ‘I raise the subject of vaccination’. The per-
centage of identical responses was 88 % and the
Spearman correlation coefficient was 0.83. The redun-
dancy might come from the strong link between re-
ported intention (‘I think about’) and reported action (‘I
raise the subject of ’). To overcome the redundancy, the
item ‘I think about vaccination’ was removed from the
questionnaire and the item ‘I raise the subject of vaccin-
ation’ was kept as it was conceptually more consistent
with the other items of the ‘PCP’s commitment to the vac-
cination approach’ domain, all depicting action rather than
intention.
Final conceptual framework
The results of the PCA suggested an alternative concep-
tual framework of the DIVA questionnaire, including 10
empirical thematic domains and the ‘PCP’s commitment
to the vaccination approach’ domain. However, the em-
pirical conceptual framework did not provide signifi-
cantly better results over the hypothetical conceptual
framework. Besides, the empirical conceptual framework
held more thematic domains than the hypothetical one
(10 vs. 6 thematic domains respectively) and thus
depicted a more complex picture of the determinants of
intentions of PCPs to vaccinate. Therefore, as no loss of
information was incurred by selecting a more parsimoni-
ous conceptual framework, the hypothetical conceptual
framework with six thematic domains and one commit-
ment domain was selected as the final structure of the
DIVA questionnaire (see Additional file 1: Appendix A).
Rasch modelling
The Rasch model fit is presented in Table 2. The resid-
uals were within the range of acceptability for all items
except for items ‘I am used to prescribing vaccination’
(−6.14) and ‘I insist on vaccination if the patient is reluc-
tant’ (-2.73). The former asks about habits of vaccination
and is less factual than other items. It was therefore de-
cided to change the wording to ‘I prescribe vaccination’
to be consistent with other items. The latter was deemed
borderline and was kept unchanged. The order of items
according to their location on the latent trait followed a
theoretical model of the PCP’s commitment process and
actions with vaccination. It ranged from −0.93 for the
item ‘My attitude toward prescribing the vaccine is in
agreement with my beliefs’ to 0.88 for the item ‘I make
sure that my prescription for vaccination has been prop-
erly followed’. The item ‘Vaccination is a subject that in-
terests me’ was neutral in this process with its central
position.
In the person-item threshold distribution map, the
upper panel displays the frequency of recruited PCPs in
the study according to their position on the latent trait,
representing their level of commitment; the lower panel
displays the “thresholds” (i.e. the point on the latent trait
for which two adjacent response categories are equally
probable) for the six DIVA items of the ‘PCP’s commit-
ment to the vaccination approach’ domain (Fig. 1). The
graph showed that all items were able to distinguish
PCPs according to their level of commitment (items
cover the latent trait from −4 to 4), and that PCPs who
participated in the study were fairly committed to vac-
cination. Precisely, the graph shows that the locations
corresponding to very strong commitment (at the ex-
treme right end of the x-axis) and moderate commit-
ment (in the middle of the x-axis) were partly covered
by DIVA items whereas low commitment (at the ex-
treme left end of the x-axis) was accurately covered.
Definition of the scoring rule
For all DIVA domains, the score was obtained by calculat-
ing the mean of non-missing items and applying a linear
transformation resulting in a score ranging from 0 to 100.
For the six thematic domains, a higher score is associated
with a better perception of vaccination. For the commit-
ment domain, a higher score is associated with stronger
commitment toward vaccination. All scores were calculated
if at least half the items within a domain were completed.
Ability of DIVA scores to detect difference
The distribution of DIVA scores across the six VPDs is
detailed in Fig. 2. Overall, the ‘Adaptation to the patient’s
profile’, the ‘Information about the vaccination’ and the
‘Practical and organisational aspect’ domains showed the
lowest mean scores (58.4, 60.7, 63.9 respectively). The
mean scores were the lowest in the pneumococcus
Table 2 Rasch individual item fit - Residuals and location of all
items of the ‘PCP’s commitment to the vaccination approach’
domain (N = 1,069)
Item labels Residuals Location
My attitude toward prescribing the vaccine
is in agreement with my beliefs
0.06 −0.93
I raise the subject of vaccination −0.48 −0.54
I am used to prescribing vaccination −6.14 −0.07
Vaccination is a subject that interests me 1.27 0.10
I insist on vaccination if the patient is reluctant −2.73 0.56
I make sure that my prescription for vaccination
has been properly followed
1.30 0.88
Martinez et al. BMC Family Practice  (2016) 17:143 Page 4 of 9
infection and the HPV infection diseases. On the con-
trary, the ‘Disease characteristics and expected benefits’
and the ‘PCP’s commitment to the vaccination approach’
domains showed the highest mean scores overall (78.7
and 74.2 respectively). The mean scores were at the
highest for the measles, the pertussis and the tetanus
diseases.
Measurement properties
Cronbach’s alpha coefficients of the ‘PCP’s commitment
to the vaccination approach’ score are presented in
Table 3. They were above the recommended threshold
of 0.70 for all diseases, ranging from 0.80 (for tetanus) to
0.87 (for measles and pneumococcus infection).
The results of the construct validity of DIVA thematic
scores according to the Delphi panel’s hypotheses are de-
tailed in Table 4. In 30 out of 36 comparisons, the rank
obtained by descriptive analyses was identical or adja-
cent to the rank given by the Delphi panel. Some incon-
sistencies were observed for pertussis, seasonal influenza
and tetanus diseases.
Discussion
In this study, the DIVA questionnaire confirmed its reli-
ability and validity in a large sample of PCPs and across
a variety of VPDs. The quality of completion of the
DIVA questionnaire was very good. A few missing data
were observed for items. The analyses on the hypothet-
ical conceptual framework of the DIVA questionnaire
led to some minor adjustments: one item removed and a
few changes in three item labels. The Rasch model vali-
dated the commitment domain and its six items as a
measure of the level of commitment of PCPs in the vac-
cination against a specific disease [20].
The final 55-item DIVA questionnaire includes the six
original thematic domains, covering the concepts meas-
uring a large set of factors that influence PCPs’ attitudes
and beliefs toward vaccination including: disease charac-
teristics, vaccine properties, scientific and non-scientific
communication, practical and organizational aspects, the
patient’s profile and the PCP’s individual experience. The
DIVA questionnaire also includes a specific domain
assessing the commitment of the PCP to vaccination
against the specific disease of interest.
To our knowledge, our study was the first to present
simultaneously all the six thematic domains plus a com-
mitment domain in a measurement approach applicable
to a large variety of VPDs.
All DIVA thematic domains were identified in the lit-
erature, and several studies have explored specific deter-
minants in specific diseases [24]. The most frequently
studied domain was related to the ‘Adaptation to the
Fig. 1 Person-item threshold distribution map of items from the ‘PCP’s commitment to the vaccination approach’ domain with items scaled with
four categories (N = 1,069)
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Fig. 2 Score distribution of the DIVA questionnaire in the six vaccine-preventable diseases (N = 1,069)
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patient’s profile’ domain, which showed the lowest mean
score across our study sample. A survey was conducted
among pediatricians and family medicine physicians in
2010, before the quadrivalent HPV vaccine (HPV4) was
recommended for 11- to 12-year-old boys [25]. The
most commonly reported barrier to HPV4 was financing
(out-of-pocket cost and lack of adequate reimbursement
for vaccine). The second barrier was related to parents’
attitudes, not thinking that HPV4 was necessary for their
sons [25]. In 2008, a French survey with 1,000 family
physicians showed that physicians who did not think
that HPV vaccine had a negative effect on the image of
sexuality were more in favour of vaccination [26].
Previous studies on PCPs’ attitudes and practices in
vaccination showed that French PCPs’ concerns were fo-
cused on the safety of the vaccine [10, 12, 14, 27]. This
is partially consistent with our finding, as the ‘Disease
characteristics and expected benefits’ domain showed
high scores across all studied diseases. However, our
study showed that ‘Properties of the vaccine’ domain
was not the major concern. Rather, we found that the
‘Information about vaccination’ and the ‘Practical and
organizational aspects’ domains constituted the main
barriers to vaccination for PCPs. Other studies con-
firmed that the lack of information on vaccination and
the recommendations for vaccination might impact
vaccine uptake rates in the general public [10, 12, 14, 27].
The level of acceptance of vaccination by patients was
shown to be also an important factor that encouraged
PCPs to vaccinate [28–31]. To summarize, it seems that
PCPs are fully aware of the advantages of vaccination,
generally confident in the vaccines properties, but face dif-
ficulties when communicating to patients and addressing
practical organization of vaccination, which negatively im-
pact their commitment to vaccination.
In this study, six VPDs were chosen according to their
level of acceptance: the vaccines against measles, pertus-
sis, pneumococcus infection and tetanus (compulsory in
France) diseases have not been subject to much debate;
the vaccines against the seasonal influenza and HPV in-
fection diseases have created controversies [4, 32]. The
expected barriers toward vaccination for each of the dis-
eases were assessed with a Delphi Panel approach, and
were generally confirmed by our findings in the surveyed
population of PCPs. However, a couple of inconsisten-
cies appeared between the rank of DIVA scores given by
descriptive analyses and those given by Delphi panel in
the pertussis, seasonal influenza and tetanus diseases. In-
deed, PCPs seemed less convinced than panellists that
the disease characteristics of the seasonal influenza and
the expected benefits of vaccination were sufficient to
engage them in vaccination. This could have been influ-
enced by the debate in the A/H1N1 outbreak in 2009
[27]. The observed discrepancies between panellists and
surveyed PCPs about pertussis and tetanus vaccination
are more compelling and need further exploration.
In addition to the assessment of the determinants of
PCPs’ attitudes toward vaccination, the DIVA question-
naire specifically measures their commitment toward vac-
cination against each of the six selected VPDs. The ‘PCP’s
commitment to the vaccination approach’ domain had
very good internal consistency reliability overall and in the
six VPDs, showing its accuracy in measuring the commit-
ment of a PCP to vaccination. In addition, it was validated
by a Rasch model, encouraging future researchers to use
the ‘PCP’s commitment to the vaccination approach’ as a
Table 3 Internal consistency reliability of the ‘PCP’s
commitment to the vaccination approach’ score in the six
vaccine-preventable diseases and overall (N = 1,069)
Vaccine-preventable disease N Cronbach’s alpha
Measles 209 0.87
Pertussis 199 0.84
Pneumococcus infection 193 0.87
Seasonal influenza 196 0.84




Table 4 Comparison of the ranks of DIVA scores given by descriptive analyses of thematic scores and those given by the Delphi
panel’s propositions (in parenthesis) – N = 1,069
DIVA thematic score Vaccine-preventable diseases
Measles Pertussis Pneumococcus infection Seasonal influenza HPV infection Tetanus
Disease characteristics and expected benefits 1 (2) 1 (2) 1 (1) 1 (4) 1 (1) 1 (1)
Properties of the vaccine 2 (1) 2 (3) 2 (3) 3 (1) 2 (2) 2 (2)
Information about vaccination 4 (4) 6 (5) 5 (4) 6 (5) 5 (5) 6 (3)
Practical and organisational aspects 6 (6) 3 (6) 4 (5) 5 (6) 3 (4) 3 (5)
Adaptation to the patient’s profile 5 (5) 5 (4) 2 (2) 2 (1) 4 (3) 4 (4)
PCP’s individual experience 3 (2) 4 (1) 6 (6) 3 (3) 6 (6) 5 (6)
In bold, identical rank between those given by Delphi panel and descriptive analyses
Difference between rank obtained by descriptive analyses and rank given by Delphi panel =1; =2; =3
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stand-alone tool either as an outcome measure of inter-
vention programmes encouraging vaccination, or as an ex-
planatory factor in public health research.
We can assume that our survey has not reached PCPs
who would have strong beliefs against vaccination. How-
ever, the issue is not to convince a minority of opponents
about the relevance of vaccination for public health. Ra-
ther, the variations observed across VPDs clearly show
that the commitment to vaccine is explained by well-
identified factors. The DIVA questionnaire is the first
standardized tool examining the barriers to vaccination
that specific diseases may face and informing where efforts
should be concentrated in order to increase adoption of
positive attitudes toward vaccination by PCPs.
Conclusions
The DIVA questionnaire was found to be reliable and
valid, allowing PCPs’ attitudes and beliefs toward vaccin-
ation to be comprehensively assessed.
In a long-term perspective, the DIVA questionnaire
could help develop fine-tuned, efficient interventions to
overcome the barriers that prevent PCPs from engaging in
vaccination. Ultimately, these interventions will improve
vaccine coverage rates in the general population in France.
Furthermore, the findings on the ‘PCP’s commitment
to the vaccination approach’ domain of the question-
naire suggest the use of this domain as a stand-alone
questionnaire.
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